These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Effect of myocardial viability and coronary revascularization on clinical outcome and prognosis: a follow-up study of 161 patients with coronary heart disease]. vom Dahl J, Altehoefer C, Büchin P, Sheehan FH, Schwarz ER, Koch KC, Schulz G, Uebis R, Schöndube F, Messmer BJ, Büll U, Hanrath P. Z Kardiol; 1996 Nov; 85(11):868-81. PubMed ID: 9064949 [Abstract] [Full Text] [Related]
3. [Assessing myocardial viability in chronic myocardial infarct with 18F-fluoro-D-glucose positron emission tomography and 99mTc-MIBI SPECT]. Schneider CA, Voth E, Theissen P, Wienhard K, Wagner R, Baer FM, Sechtem U, Schicha H. Z Kardiol; 1994 Feb; 83(2):124-31. PubMed ID: 8165842 [Abstract] [Full Text] [Related]
6. [Indications for clinical applications of positron emission tomography in cardiology. Position report of the PET Cardiology Study Group of the German Society of Nuclear Medicine and the Nuclear Cardiology Study Circle of the German Society of Cardiology]. Z Kardiol; 1996 Jul; 85(7):453-68. PubMed ID: 8928543 [Abstract] [Full Text] [Related]
10. Myocardial viability assessed with fluorodeoxyglucose and PET in patients with Q wave myocardial infarction receiving thrombolysis: relationship to coronary anatomy and ventricular function. Fragasso G, Chierchia SL, Rossetti E, Sciammarella MG, Conversano A, Lucignani G, Landoni C, Calori G, Margonato A, Fazio F. Nucl Med Commun; 1997 Mar; 18(3):191-9. PubMed ID: 9106772 [Abstract] [Full Text] [Related]
11. [Positron emission tomography: principles and uses in cardiology]. Porenta G, Czernin J, Schelbert H. Wien Med Wochenschr; 1992 Mar; 142(15-16):358-66. PubMed ID: 1481541 [Abstract] [Full Text] [Related]
12. Positron emission tomography in human myocardial ischemia. Schelbert HR, Schwaiger M. Herz; 1987 Feb; 12(1):22-40. PubMed ID: 3493961 [Abstract] [Full Text] [Related]
14. [Hibernating myocardium and the 'no reflow' phenomenon: a study of absolute regional myocardial perfusion and glucose metabolism using positron emission tomography in chronic and acute heart disorders]. Maes A, Nuyts J. Verh K Acad Geneeskd Belg; 1997 Feb; 59(3):133-60. PubMed ID: 9490915 [Abstract] [Full Text] [Related]
16. Imaging of cardiac metabolism using radiolabelled glucose, fatty acids and acetate. Visser FC. Coron Artery Dis; 2001 Feb; 12 Suppl 1():S12-8. PubMed ID: 11286301 [Abstract] [Full Text] [Related]
17. Superiority of C-11 acetate compared with F-18 fluorodeoxyglucose in predicting myocardial functional recovery by positron emission tomography in patients with acute myocardial infarction. Rubin PJ, Lee DS, Dávila-Román VG, Geltman EM, Schechtman KB, Bergmann SR, Gropler RJ. Am J Cardiol; 1996 Dec 01; 78(11):1230-5. PubMed ID: 8960580 [Abstract] [Full Text] [Related]
18. Myocardial metabolic imaging by means of fluorine-18 deoxyglucose/technetium-99m sestamibi dual-isotope single-photon emission tomography. Stoll HP, Hellwig N, Alexander C, Ozbek C, Schieffer H, Oberhausen E. Eur J Nucl Med; 1994 Oct 01; 21(10):1085-93. PubMed ID: 7828618 [Abstract] [Full Text] [Related]
19. Myocardial viability: fluorine-18-deoxyglucose positron emission tomography in prediction of wall motion recovery after revascularization. Knuuti MJ, Saraste M, Nuutila P, Härkönen R, Wegelius U, Haapanen A, Bergman J, Haaparanta M, Savunen T, Voipio-Pulkki LM. Am Heart J; 1994 Apr 01; 127(4 Pt 1):785-96. PubMed ID: 8154416 [Abstract] [Full Text] [Related]
20. [Relation between myocardial perfusion, myocardial necrosis and residual glucose metabolism as a vitality parameter in the post-ischemic myocardium following coronary reperfusion]. Sochor H. Acta Med Austriaca Suppl; 1989 Apr 01; 39():1-36. PubMed ID: 2787948 [Abstract] [Full Text] [Related] Page: [Next] [New Search]